AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Cloud computing #High throughput screening #Lab automation #Machine learning #SLAS2023

How ML and automation are changing the future of protein therapeutics

Kristen Hopson, Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yue Liu, Associate Director, HTS at Generate Biomedicines, reflect on the impact of artificial intelligence (AI), machine learning (ML), cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research. Proteins are the basic… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Webinar: Choose the right drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Bioengineering #Biology #Lab automation #SLAS2023

Listen now: Connecting lab automation to decision-making

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode three, Connecting lab automation to decision-making. In this episode, we… Read More

#News

#AI / data analytics / healthtech / informatics #Automation / robotics #Ginkgo Bioworks #Lab automation #Lab technology #SLAS2023 #Synthetic biology

Connecting lab automation to decision-making

Ashwin Pillai is Test Engineer 3 in HTS & Assay Development at Ginkgo Bioworks, a company whose mission is to make biology easier to engineer. Ahead of his presentation in the Automation Technologies Track at SLAS2023, Pillai shares insight on data and how we can connect lab automation to decisions. Read More

#Exclusive Content

Social media
#AI / data analytics / healthtech / informatics #Biotechnology #Business #Social media

Biotech goes social: Tips for effective social media marketing

Kristina Tatiossian, PhD, founder of Arkitekt Agency, looks at how biotech companies are currently using social media and provides a five-step guide for how to make the most of this ubiquitous marketing tool. Biotechnology organisations can leverage social media for a variety of purposes, from boosting awareness and increasing engagement,… Read More

#Business & Investment #Exclusive Content

Laboratory technology
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Charles River #Collaboration #DNA technology #High throughput screening #Medicinal chemistry #Partnership #Pioneering Medicines

Partners enter multi-programme drug discovery agreement

Charles River Laboratories and Pioneering Medicines have entered a multi-programme agreement that gives Pioneering Medicines access to artificial intelligence (AI) model Logica.  Through the agreement, Pioneering Medicines will apply Logica across a portfolio of targets with the aim of creating optimised small molecules… Read More

#News

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #SLAS2023 #Therapeutics

Podcast: Acquiring deeper insights and acceleration with AI

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode two, Acquiring deeper insights and acceleration with AI. At IBM… Read More

#News

#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #Labforward #Podcast #Sitting Down With podcast

The integration puzzle: Open ecosystem can unlock the potential of lab data

The latest sponsored DDW Sitting Down With podcast features Simon Bungers, CEO, Labforward and explains why the promises of big data, AI and ML are only illusions if the integration puzzle isn’t solved. Among the topics Lu Rahman, Publishing Director, DDW discusses with Bungers are connectivity and interoperability in the… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #Labforward #Sitting Down With podcast

New podcast: Unlock the potential of lab data

The latest sponsored DDW Sitting Down With podcast features Simon Bungers, CEO, Labforward and explains why the promises of big data, AI and ML are only illusions if the integration puzzle isn’t solved. Among the topics Lu Rahman, Publishing Director, DDW discusses with Bungers are connectivity and interoperability in the… Read More

#News

#AI / data analytics / healthtech / informatics #Cancer research #Collaboration #Drug development #Drug discovery #Oncology #Partnership

This week in drug discovery (13-17 February)

News round-up for 13-17 February by DDW Digital Content Editor Diana Spencer.  The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of… Read More

#News

Big genomic data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Bioinformatics #Collaboration #Genetics / genomics #Oncology #Partnership

Partners hope to “chart a new era of drug discovery”

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments.  In this partnership, M2GEN will license its real-world data set (RWD) to Zephyr AI, while Zephyr AI will… Read More

#Cancer Research #News

San Diego skyline
#AI / data analytics / healthtech / informatics #Data automation #Drug discovery #Events #Life sciences #SLAS2023

SLAS2023 is ready for you

Ahead of SLAS2023 in San Diego, Jill Hronek, SLAS Director, Marketing & Communications, shares her enthusiasm for the opportunities, products, technologies and innovation that this event brings together. Data is the glue that keeps automation tools working together. We’re accelerating into another year of innovation and automation at SLAS: our… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Event: How to choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Events #Interview #SLAS2023

Acquiring deeper insights and acceleration with AI

At IBM Research, a group of scientists and researchers from around the globe is working to support the power of the scientific method to invent what’s next for IBM, its clients, and the world. Joshua Smith, PhD, IBM TJ Watson Research Center, speaks with DDW’s Megan Thomas about AI, and… Read More

#Exclusive Content

Tumour microenvironment
#Absci #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer research #Oncology #St John’s Cancer Institute #Tumours

Partners use AI to speed up development of cancer therapies

AI company Absci and St John’s Cancer Institute (SJCI) have entered a partnership to uncover breakthrough cancer therapies.   The companies will use Absci’s Integrated Drug Creation platform, which combines generative AI models and proprietary wet-lab technologies, and SJCI’s cancer biospecimen repository and molecular database to identify new… Read More

#Cancer Research #News

#AI / data analytics / healthtech / informatics #Drug discovery #Events #SLAS2023

SLAS2023: We have the building blocks, onto the building

By DDW Multimedia Editor Megan Thomas. In the time that has passed since SLAS2022 in Boston, USA, the drug discovery industry has had to deal with all manner of external obstacles, from the war in Ukraine, to how Brexit has changed the world’s relationship with the UK, and the post-Covid-19… Read More

#Exclusive Content